Healthcare provider profile · identity verified

Maggie Benson

Internal Medicine · ERIE, PA · NPI 1710120555

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	487	132
Lisinopril	Lisinopril	260	63
Levothyroxine Sodium	Levothyroxine Sodium	258	66
Amlodipine Besylate	Amlodipine Besylate	243	74
Rosuvastatin Calcium	Rosuvastatin Calcium	216	71
Pantoprazole Sodium	Pantoprazole Sodium	186	50
Losartan Potassium	Losartan Potassium	176	43
Hydrochlorothiazide	Hydrochlorothiazide	163	46
Omeprazole	Omeprazole	152	44
Metoprolol Succinate	Metoprolol Succinate	149	38
Escitalopram Oxalate	Escitalopram Oxalate	139	33
Eliquis	Apixaban	122	27
Fluticasone Propionate	Fluticasone Propionate	120	41
Gabapentin	Gabapentin	118	28
Alendronate Sodium	Alendronate Sodium	97	26
Metformin Hcl	Metformin Hcl	94	29
Famotidine	Famotidine	88	27
Jardiance	Empagliflozin	82	17
Buspirone Hcl	Buspirone Hcl	77	15
Furosemide	Furosemide	77	21
Duloxetine Hcl	Duloxetine Hcl	75	22
Pravastatin Sodium	Pravastatin Sodium	70	20
Metoprolol Tartrate	Metoprolol Tartrate	67	17
Simvastatin	Simvastatin	67	13
Albuterol Sulfate Hfa	Albuterol Sulfate	65	23
Potassium Chloride	Potassium Chloride	63	14
Tamsulosin Hcl	Tamsulosin Hcl	62	17
Carvedilol	Carvedilol	60	18
Metformin Hcl Er	Metformin Hcl	60	20
Ezetimibe	Ezetimibe	58	20
Repatha Sureclick	Evolocumab	58	suppressed
Trazodone Hcl	Trazodone Hcl	53	15
Meloxicam	Meloxicam	52	15
Xarelto	Rivaroxaban	52	11
Allopurinol	Allopurinol	48	13
Bupropion Hcl Sr	Bupropion Hcl	47	14
Glipizide Er	Glipizide	47	11
Synthroid	Levothyroxine Sodium	47	11
Sertraline Hcl	Sertraline Hcl	46	16
Atenolol	Atenolol	45	13
Ketoconazole	Ketoconazole	44	14
Clopidogrel	Clopidogrel Bisulfate	43	11
Fluoxetine Hcl	Fluoxetine Hcl	43	suppressed
Spironolactone	Spironolactone	42	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	11
Ozempic	Semaglutide	41	suppressed
Tramadol Hcl	Tramadol Hcl	41	11
Alprazolam	Alprazolam	38	13
Hydralazine Hcl	Hydralazine Hcl	38	15
Triamcinolone Acetonide	Triamcinolone Acetonide	38	20
Trulicity	Dulaglutide	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	suppressed
Prednisone	Prednisone	35	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	34	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	11
Tizanidine Hcl	Tizanidine Hcl	34	11
Diazepam	Diazepam	33	suppressed
Lorazepam	Lorazepam	33	13
Oxycodone Hcl	Oxycodone Hcl	32	suppressed
Ondansetron Odt	Ondansetron	31	12
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	22
Baclofen	Baclofen	29	suppressed
Bumetanide	Bumetanide	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Mounjaro	Tirzepatide	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	21
Lovastatin	Lovastatin	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Methadone Hcl	Methadone Hcl	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Mupirocin	Mupirocin	18	11
Clonazepam	Clonazepam	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Azithromycin	Azithromycin	16	13
Enalapril Maleate	Enalapril Maleate	16	suppressed
Icosapent Ethyl	Icosapent Ethyl	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Tradjenta	Linagliptin	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Finasteride	Finasteride	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	11
Telmisartan	Telmisartan	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Ciclopirox	Ciclopirox Olamine	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	11	suppressed
Temazepam	Temazepam	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error